retatrutide weight loss trials results Results: 24% in 48 Weeks Air Mail | On TikTok,

Oral GLP-1 Medications: Comparing Your Options The weight loss medication landscape continues to evolve rapidly

Before GLP-1s, eating according to my intentions was a daily challenge

Approval expected 2027-2028 after NDA submission Phase 2 vs Phase 3: Phase 2 (Jastreboff et al., NEJM 2023) showed 24.2% weight loss at 48 weeks

[DOI] [PMC free article] [PubMed] [Google Scholar] 182.Ling C.H.Y., de Craen A.J.M., Slagboom P.E., Gunn D.A., Stokkel M.P.M., Westendorp R.G.J., Maier A.B

[DOI] [PMC free article] [PubMed] [Google Scholar] 250.Liu D., Huang Y., Huang C., Yang S., Wei X., Zhang P., Guo D., Lin J., Xu B., Li C., et al

Klaar om smaakvol slimmer te kiezen?